The placebo effect in rheumatology: New data

Joint Bone Spine

Volumn 78, Issue 2, 2011, Pages 161-165

  Berthelot, Jean Marie ^a  

^a HÔTEL DIEU   (France)

Author keywords

Bias; Blinding; Ethics; Nocebo; Placebo; Placebo effect; Publication bias

Indexed keywords

BUPRENORPHINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GLUCOCORTICOID; HYALURONIC ACID; MORPHINE; NALOXONE; NONSTEROID ANTIINFLAMMATORY AGENT; PROGLUMIDE; TRAMADOL;

ACUPUNCTURE; FIBROMYALGIA; HUMAN; ISCHIALGIA; OSTEOARTHRITIS; OUTCOME ASSESSMENT; PAIN; PHYSIOTHERAPY; PLACEBO EFFECT; RHEUMATIC DISEASE; RHEUMATOLOGY; SHAM PROCEDURE; SHORT SURVEY;

ANTIRHEUMATIC AGENTS; CENTRAL NERVOUS SYSTEM; CHOLECYSTOKININ; ETHICS, MEDICAL; HUMANS; PLACEBO EFFECT; RHEUMATIC DISEASES;

EID: 79952244335     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2010.08.006     Document Type: Short Survey

References (59)

1. Enck P., Benedetti F., Schedlowski M. New insights into the placebo and nocebo responses. Neuron 2008, 59:195-206.
2. Pollo A., Benedetti F. Placebo response: relevance to the rheumatic diseases. Rheum Dis Clin North Am 2008, 34:331-349.
3. Breidert M., Hofbauer K. Placebo: misunderstandings and prejudices. Dtsch Artzebl Int 2009, 106:751-755.
4. Gilron I., Bailey J.M., Tu D., et al. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005, 352:1324-1334.
5. Berthelot J.M., Blanchais A., Marhadour T., et al. Fluctuations in disease activity scores for inflammatory joint disease in clinical practice: do we need a solution?. Joint Bone Spine 2009, 76:126-128.
6. Berthelot J.M., Tortellier L., Lavy-Bregeon D., et al. High intraindividual week-to-week variability in BASDAI and BASFI values: are several evaluations needed before starting or stopping TNFalpha antagonist therapy for spondyloarthropathies?. Joint Bone Spine 2008, 75:167-171.
7. Nieuwkerk P.T., Sprangers M.A. Each measure of patient-reported change provides useful information and is susceptible to bias: the need to combine methods to assess their relative validity. Arthritis Care Res 2009, 61:1623-1625.
8. Hrobjartsson A., Gotzsche P.C. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 2001, 344:1594-1602.
9. Wampold B.E., Minami T., Tierney S.C., et al. The placebo is powerful: estimating placebo effects in medicine and psychotherapy from randomized clinical trials. J Clin Psychol 2005, 61:835-854.
10. Geers A.L., Kosbab K., Helfer S.G., et al. Further evidence for individual differences in placebo responding: an interactionist perspective. J Psychosom Res 2007, 62:563-570.
11. Morton D.L., Watson A., El-Deredy W., et al. Reproducibility of placebo analgesia: Effect of dispositional optimism. Pain 2009, 146:194-198.
12. Vase L., Riley J.L., Price D.D. A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia. Pain 2002, 99:443-452.
13. Hrobjartsson A., Gotzsche P.C. Unsubstantiated claims of large effects of placebo on pain: serious errors in meta-analysis of placebo analgesia mechanism studies. J Clin Epidemiol 2006, 59:336-338.
14. Wager T.D., Rilling J.K., Smith E.E., et al. Placebo-induced changes in fMRI in the anticipation and experience of pain. Science 2004, 303:1162-1166.
15. Price D.D., Craggs J., Verne G.N., et al. Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients. Pain 2007, 127:63-72.
16. Kong J., Gollub R.L., Rosman I.S., et al. Brain activity associated with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging. J Neurosci 2006, 26:381-388.
17. Scott D.J., Stohler C.S., Egnatuk C.M., et al. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch Gen Psychiatry 2008, 65:220-231.
18. Benedetti F., Lanotte M., Lopiano L., et al. When words are painful: unravelling the mechanisms of the nocebo effect. Neuroscience 2007, 147:260-271.
19. Colloca L., Benedetti F. Nocebo hyperalgesia: how anxiety is turned into pain. Curr Opin Anaesthesiol 2007, 20:435-439.
20. Finniss D.G., Kaptchuk T.J., Miller F., et al. Biological, clinical, and ethical advances of placebo effects. Lancet 2010, 375:686-695.
21. Qiu Y.H., Wu X.Y., Xu H., et al. Neuroimaging study of placebo analgesia in humans. Neurosci Bull 2009, 25:277-282.
22. Eippert F., Finsterbusch J., Bingel U., et al. Direct evidence for spinal cord involvement in placebo analgesia. Science 2009, 326:404.
23. Matre D., Casey K.L., Knardahl S. Placebo-induced changes in spinal cord pain processing. J Neurosci 2006, 26:559-563.
24. Kong J., Kaptchuk T.J., Polich G., et al. Placebo analgesia: findings from brain imaging studies and emerging hypotheses. Rev Neurosci 2007, 18:173-190.
25. Zhang W., Robertson J., Jones A.C., et al. The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis 2008, 67:1716-1723.
26. Charlton B.G. Covert drug dependence should be the null hypothesis for explaining drug-withdrawal-induced clinical deterioration: The necessity for placebo versus drug withdrawal trials on normal control subjects. Med Hypotheses 2010, 74:761-763.
27. Staud R., Price D.D. Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: how study designs can affect placebo factors. Pain 2008, 136:232-234.
28. Krummenacher P., Candia V., Folkers G., et al. Prefrontal cortex modulates placebo analgesia. Pain 2010, 148:368-374.
29. Zubieta J.K., Stohler C.S. Neurobiological mechanisms of placebo responses. Ann N Y Acad Sci 2009, 1156:198-210.
30. De la Fuente-Fernandez R. The placebo-reward hypothesis: dopamine and the placebo effect. Parkinsonism Relat Disord 2009, 15(Suppl. 3):S72-S74.
31. Miller F.G., Rosenstein D.L. The nature and power of the placebo-effect. J Clin Epidemiol 2006, 59:331-335.
32. Turner E.H., Matthews A.M., Linardatos E., et al. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008, 358:252-260.
33. Colloca L., Benedetti F. Placebo analgesia induced by social observational learning. Pain 2009, 144:28-34.
34. Colloca L., Sigaudo M., Benedetti F. The role of learning in nocebo and placebo effects. Pain 2008, 136:211-218.
35. Colloca L., Lopiano L., Lanotte M., et al. Overt versus covert treatment for pain, anxiety, and Parkinson's disease. Lancet Neurol 2004, 3:679-684.
36. Nüesch E., Reichenbach S., Trelle S., et al. The importance of allocation concealment and patient blinding in osteoarthritis trials: a meta-epidemiologic study. Arthritis Care Res 2009, 61:1633-1641.
37. Boutron I., Moher D., Altman D.G., et al. Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments. Ann Intern Med 2008, 148:W60-W66.
38. Kaptchuk T.J., Shaw J., Kerr C.E., et al. " Maybe I made up the whole thing": placebos and patients' experiences in a randomized controlled trial. Cult Med Psychiatry 2009, 33:382-411.
39. Berthelot J.M., Maugars Y., Abgrall M., et al. Interindividual variations in beliefs about the placebo effect: a study in 300 rheumatology inpatients and 100 nurses. Joint Bone Spine 2001, 68:65-70.
40. Van Die M.D., Bone K.M., Burger H.G., et al. Are we drawing the right conclusions from randomised placebo-controlled trials? A post-hoc analysis of data from a randomised controlled trial. BMC Med Res Methodol 2009, 9:41.
41. Moffet H.H. Sham acupuncture may be as efficacious as true acupuncture: a systematic review of clinical trials. J Altern Complement Med 2009, 15:213-216.
42. Takakura N., Yajima H. Analgesic effect of acupuncture needle penetration: a double-blind crossover study. Open Med 2009, 19:e54-61.
43. Valat J.P., Giraudeau B., Rozenberg S., et al. Epidural corticosteroid injections for sciatica: a randomised, double blind, controlled clinical trial. Ann Rheum Dis 2003, 62:639-643.
44. Valat J.P., Rozenberg S. Local corticosteroid injections for low back pain and sciatica. Joint Bone Spine 2008, 75:403-407.
45. Klenerman L., Greenwood R., Davenport H.T., et al. Lumbar epidural injections in the treatment of sciatica. Br J Rheumatol 1984, 23:35-38.
46. Licciardone J.C., Russo D.P. Blinding protocols, treatment credibility, and expectancy: methodologic issues in clinical trials of osteopathic manipulative treatment. J Am Osteopath Assoc 2006, 106:457-463.
47. Hawk C., Long C.R., Reiter R., et al. Issues in planning a placebo-controlled trial of manual methods: results of a pilot study. J Altern Complement Med 2002, 8:21-32.
48. Forestier R., Desfour H., Tessier J.M., et al. Spa therapy in the treatment of knee osteoarthritis: a large randomised multicentre trial. Ann Rheum Dis 2010, 69:660-665.
49. Forestier R., André-Vert J., Guillez P., et al. Non-drug treatment (excluding surgery) in rheumatoid arthritis: clinical practice guidelines. Joint Bone Spine 2009, 76:691-698.
50. Dogru H., Basaran S., Sarpel T. Effectiveness of therapeutic ultrasound in adhesive capsulitis. Joint Bone Spine 2008, 75:455-550.
51. Fardellone P., Cortet B., Legrand E., et al. Cost-effectiveness model of using zoledronic acid once a year versus current treatment strategies in postmenopausal osteoporosis. Joint Bone Spine 2010, 77:53-57.
52. Martin A.L., Katz J. Inclusion of authorized deception in the informed consent process does not affect the magnitude of the placebo effect for experimentally induced pain. Pain 2010, 149:208-215.
53. Cherniack E.P. Would the elderly be better off if they were given more placebos?. Geriatr Gerontol Int 2010, 10:131-137.
54. Miller F.G., Colloca L. The legitimacy of placebo treatments in clinical practice: evidence and ethics. Am J Bioeth 2009, 9:39-47.
55. Zhang W., Nuki G., Moskowitz R.W., et al. OARSI recommendations for the management of hip and knee osteoarthritis Part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage 2010, 18:476-499.
56. Kallmes D.F., Comstock B.A., Heagerty P.J., et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med 2009, 361:569-579.
57. Buchbinder R., Osborne R.H., Ebeling P.R., et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med 2009, 361:557-568.
58. Liu J.T., Liao W.J., Tan W.C., et al. Balloon kyphoplasty versus vertebroplasty for treatment of osteoporotic vertebral compression fracture: a prospective, comparative, and randomized clinical study. Osteoporosis Int 2010, 21:359-364.
59. Wendling D., Runge M., Toussirot E., et al. Vertebral osteitis adjacent to kyphoplasty. Joint Bone Spine 2010, 77:67-69.